Showing 1 - 20 results of 130 for search '"neuroendocrine tumor"', query time: 0.07s Refine Results
  1. 1

    Primary Neuroendocrine Tumor in Brain by Ryota Tamura, Yoshiaki Kuroshima, Yoshiki Nakamura

    Published 2014-01-01
    “…The incidence of brain metastases for neuroendocrine tumor (NET) is reportedly 1.5~5%, and the origin is usually pulmonary. …”
    Get full text
    Article
  2. 2
  3. 3

    Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the Liver by Martin Vyleta, Douglas Coldwell

    Published 2011-01-01
    “…Surgical excision remains the preferred treatment for resectable hepatic metastases of neuroendocrine tumors. In cases of more disseminated hepatic disease, transarterial radioembolization with Yttrium-90- (90Y-) labeled microspheres has been demonstrated as a viable option for symptom and locoregional tumor control. …”
    Get full text
    Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Hepatic Arterial Embolization for the Treatment of Metastatic Neuroendocrine Tumors by Eric Lee, H. Leon Pachter, Umut Sarpel

    Published 2012-01-01
    “…Neuroendocrine tumors (NETs) have a high predilection for metastasizing to the liver and can cause severe debilitating symptoms adversely affecting quality of life. …”
    Get full text
    Article
  9. 9

    Pancreatic Neuroendocrine Tumor in the Setting of Dorsal Agenesis of the Pancreas by Samih Nassif, Cecilia Ponchiardi, Teviah Sachs

    Published 2016-01-01
    “…We present the case of a pancreatic neuroendocrine tumor in a patient with dorsal agenesis of the pancreas, with a review of the related literature.…”
    Get full text
    Article
  10. 10

    Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors by Callisia N. Clarke, Paul Cockrum, Thomas J.R. Beveridge, Michelle Jerry, Donna McMorrow, Anh Thu Tran, Alexandria T. Phan

    Published 2023-12-01
    “…**Background:** Long-acting somatostatin analog therapy (LA-SSA) is recommended as first-line therapy for treatment of unresectable or metastatic neuroendocrine tumors (NETs). Understanding treatment sequencing and dosing patterns of LA-SSA is essential for clinical decision-making to provide value-based management of NETs. …”
    Get full text
    Article
  11. 11

    Cauda equina neuroendocrine tumor: Report of a rare case by Guoyun Zhao, Zhengliang Fan, Qinghua Zou, Rong Yang

    Published 2025-02-01
    Subjects: “…Cauda equina neuroendocrine tumors…”
    Get full text
    Article
  12. 12
  13. 13

    Treatment of Liver Metastases in Patients with Neuroendocrine Tumors of Gastroesophageal and Pancreatic Origin by Ping Gu, Jennifer Wu, Elliot Newman, Franco Muggia

    Published 2012-01-01
    “…Well-to-moderately differentiated neuroendocrine tumors of gastroesophageal and pancreatic origin (GEP-NETs) with liver metastasis are a heterogeneous group of malignancies for which a range of therapeutic options have been employed. …”
    Get full text
    Article
  14. 14

    Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation by Ilenia Bartolini, Lapo Bencini, Matteo Risaliti, Maria Novella Ringressi, Luca Moraldi, Antonio Taddei

    Published 2018-01-01
    “…Incidental diagnosis of pancreatic neuroendocrine tumors (PanNETs) greatly increased in the last years. …”
    Get full text
    Article
  15. 15

    Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors by Paola Di Giacinto, Francesca Rota, Laura Rizza, Davide Campana, Andrea Isidori, Andrea Lania, Andrea Lenzi, Paolo Zuppi, Roberto Baldelli

    Published 2018-01-01
    “…Background. Neuroendocrine tumors (NETs) are characterized by having behavior and prognosis that depend upon tumor histology, primary site, staging, and proliferative index. …”
    Get full text
    Article
  16. 16

    Recurrent Adenomatous Neuroendocrine Tumor of the Middle Ear: A Diagnostic Challenge by J. Vilain, J.-C. Degols, S. Ledeghen

    Published 2018-01-01
    “…Middle ear adenomatous neuroendocrine tumor (MEANT) poses a diagnostic challenge. …”
    Get full text
    Article
  17. 17

    Dilemmas in Endoscopic Management of Rectal Neuroendocrine Tumors: A Case-Based Discussion by Brian P. Rajca, Mihir S. Wagh

    Published 2015-01-01
    “…Rectal neuroendocrine tumors are uncommon neoplasms that historically were regarded as having an indolent course. …”
    Get full text
    Article
  18. 18
  19. 19

    Surgical planning of small intestine neuroendocrine tumors: the concept of mesenteric tumor deposits by Romain L’Huillier, Gilles Poncet, Arnaud Pasquer, Thomas Walter, Catherine Lombard-Bohas, Valérie Hervieu, Bénédicte Cayot, Pierre-Jean Valette, Helen Cheung, Laurent Milot

    Published 2025-02-01
    “…The mesenteric extension of small neuroendocrine tumors is the surgical limiting factor because of the risk of postoperative short bowel syndrome due to superior mesenteric artery involvement. …”
    Get full text
    Article
  20. 20

    Ectopic ACTH Syndrome Emerging 5 Years after the Diagnosis of Neuroendocrine Tumor by Minghao Liu, Diane Hamele-Bena, John Ausiello, Gabrielle Page-Wilson

    Published 2019-01-01
    “…Ectopic ACTH syndrome (EAS) arising years after the diagnosis of a neuroendocrine tumor (NET) is exceedingly rare. We describe a case of EAS occurring five years after the diagnosis of a metastatic lung NET in a 61-year-old woman. …”
    Get full text
    Article